Drug information for ZOFRAN ODT

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
TABLET, ORALLY DISINTEGRATING; ORAL 4MG Prescription AB  ONDANSETRON Ondansetron GLAXOSMITHKLINE 20781
2011-12-20 Other Important Information from FDA

2011-09-16 Letter

2011-09-16 Label

2010-09-29 Label

2010-09-27 Letter

2007-09-26 Review

2006-09-18 Letter

2006-08-23 Label

2006-01-06 Letter

2004-12-03 Label

2004-12-02 Letter

2004-07-01 Letter

1999-01-27 Letter

1999-01-27 Review

1999-01-27 Label
TABLET, ORALLY DISINTEGRATING; ORAL 8MG Prescription AB (Reference Drug) ONDANSETRON Ondansetron GLAXOSMITHKLINE   "

Drug Adverse Effects information for ZOFRAN ODT

Role code Indications Reaction # Reports
C MULTIPLE MYELOMA DYSPHAGIA 2
C MULTIPLE MYELOMA FEBRILE NEUTROPENIA 1
C MULTIPLE MYELOMA MULTIPLE MYELOMA 2
C MULTIPLE MYELOMA PNEUMONIA ASPIRATION 2
C NAUSEA MULTIPLE MYELOMA 2
C PAIN MULTIPLE MYELOMA 2
C VOMITING MULTIPLE MYELOMA 2
Ads by Google